Skip to search formSkip to main contentSkip to account menu

Capsaicin 0.08 MG/MG Medicated Patch [Qutenza]

Known as: Qutenza 8 % Medicated Patch, Qutenza KIT, capsaicin 640 ug in 1 cm2 CUTANEOUS PATCH [Qutenza] 
National Institutes of Health

Related topics

Related topics

7 relations
CapsaicinMedicated PatchQutenzadiethylene glycol monoethyl ether

Broader (1)

Capsaicin Medicated Patch [Qutenza]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Capsaicin 8% Dermal Patch: A Review in Peripheral Neuropathic Pain
The adhesive capsaicin dermal patch (Qutenza®) delivers a high concentration (8% w/w) of synthetic capsaicin, a highly selective… 
2016
2016
The Role of Qutenza® (Topical Capsaicin 8%) in Treating Neuropathic Pain from Critical Ischemia in Patients with End-Stage Renal Disease: An Observational Cohort Study.
OBJECTIVE Current treatment strategies for painful critical ischemia in patients with end-stage renal disease (ESRD) are… 
2016
2016
The Role of Qutenza® (Topical Capsaicin 8%) in Treating Neuropathic Pain from Critical Ischemia in Patients with End-Stage Renal Disease: An Observational Cohort Study
Objective. Current treatment strategies for painful critical ischemia in patients with end-stage renal disease (ESRD) are… 
2016
2016
Patch de capsaicine 8 % (Qutenza®) en pratique courante : résultats de l’étude post-inscription QAPSA demandée par la Haute Autorité de santé
2015
2015
Étude coût-conséquences sur la capsaïcine en patch cutané dans un CHU français
Resume Objectifs L’efficacite, le profil de tolerance et l’impact economique de la capsaicine en patch (Qutenza®), dans la prise… 
2014
2014
Capsaicin 8 % as a cutaneous patch (Qutenza™): analgesic effect on patients with peripheral neuropathic pain
Evaluation of the analgesic effect after a single application of the capsaicin 8 % cutaneous patch (Qutenza™) in 37 patients… 
2014
2014
Qutenza® Estimated Costs Per Patient In Primary Versus Secondary Care. A Comparison Between Qutenza®, Pregabalin and Lidocaine for the Treatment of Peripheral Neuropathic Pain.
2014
2014
Registre observationnel de l’efficacité et de la tolérance de la capsaïcine 8 % (Qutenza®) dans les douleurs neuropathiques périphériques localisées pharmacorésistantes
RésuméLes douleurs neuropathiques localisées peuvent bénéficier d’un traitement par la capsaïcine 8 % après échec des th… 
Highly Cited
2013
Highly Cited
2013
Efficacy of Qutenza® (capsaicin) 8% patch for neuropathic pain: A meta-analysis of the Qutenza Clinical Trials Database
2011
2011
F253 TREATMENT OF NEUROPATHIC PAIN WITH THE CAPSAICIN 8% PATCH (QUTENZA™): IS PRE-TREATMENT WITH LIDOCAINE NECESSARY?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)